Elevance Health ELV · USD
Health Care · Health Care Providers & Services · US listing · 🇺🇸 United States
S&P 500
418.25
-1.73%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$199.13bn
FY2016FY2025
Net income
$5.66bn
FY2016FY2025
Free cash flow
$3.17bn
FY2016FY2025
Shareholders' equity
$43.88bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $199.13bn | $176.81bn | $171.34bn | $156.59bn | $138.64bn | $121.87bn | $104.21bn | $92.11bn | $90.04bn | $84.98bn |
| Gross profit | $50.90bn | $49.24bn | $47.01bn | $39.95bn | $35.99bn | $33.82bn | $22.43bn | $20.21bn | $17.80bn | $18.14bn |
| Operating income | $8.11bn | $8.89bn | $8.74bn | $8.45bn | $8.95bn | $7.71bn | $6.73bn | $5.84bn | $4.99bn | $5.42bn |
| Net income | $5.66bn | $5.98bn | $5.99bn | $5.89bn | $6.10bn | $4.57bn | $4.81bn | $3.75bn | $3.84bn | $2.47bn |
| Diluted earnings per share | 25.53 | 25.88 | 25.39 | 24.44 | 24.86 | 18.21 | 18.63 | 14.30 | 14.59 | 9.19 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $121.49bn | $116.89bn | $108.93bn | $102.75bn | $97.46bn | $88.28bn | $78.25bn | $72.47bn | $71.46bn | $66.39bn |
| Cash and short-term investments | $9.49bn | $8.29bn | $6.53bn | $7.39bn | $4.88bn | $5.74bn | $4.94bn | $3.93bn | $3.61bn | $4.08bn |
| Total liabilities | $77.47bn | $75.46bn | $69.52bn | $66.42bn | $61.33bn | $55.08bn | $46.53bn | $43.93bn | $44.96bn | $41.29bn |
| Debt | $32.05bn | $31.23bn | $25.12bn | $24.11bn | $23.03bn | $20.04bn | $20.09bn | $19.21bn | $19.93bn | $15.73bn |
| Shareholders' equity | $43.88bn | $41.31bn | $39.31bn | $36.24bn | $36.06bn | $33.20bn | $31.73bn | $28.54bn | $26.50bn | $25.10bn |
| Shares outstanding | 222m | 231m | 236m | 241m | 246m | 251m | 258m | 262m | 263m | 269m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $4.29bn | $5.81bn | $8.06bn | $8.40bn | $8.36bn | $10.69bn | $6.06bn | $3.83bn | $4.18bn | $3.20bn |
| Capital spending | −$1.12bn | −$1.26bn | −$1.30bn | −$1.15bn | −$1.09bn | −$1.02bn | −$1.08bn | −$1.21bn | −$790.2m | −$583.6m |
| Free cash flow | $3.17bn | $4.55bn | $6.76bn | $7.25bn | $7.28bn | $9.67bn | $4.98bn | $2.62bn | $3.39bn | $2.62bn |
| Dividends paid | −$1.53bn | −$1.51bn | −$1.40bn | −$1.23bn | −$1.10bn | −$954.0m | −$818.0m | −$776.0m | −$704.9m | −$684.0m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $50.47bn | $50.18bn | $49.75bn | $50.71bn | $49.78bn | $48.89bn | $45.44bn | $45.15bn |
| Gross profit | $44.98bn | $9.10bn | $11.68bn | $12.57bn | $13.07bn | $13.58bn | $11.94bn | $12.20bn |
| Operating income | $2.06bn | $2.66bn | $581.0m | $1.76bn | $2.63bn | $3.14bn | $946.0m | $1.71bn |
| Net income | $1.46bn | $1.76bn | $547.0m | $1.19bn | $1.74bn | $2.18bn | $418.0m | $1.02bn |
| Diluted earnings per share | 6.71 | 8.10 | 2.47 | 5.36 | 7.86 | 9.84 | 1.81 | 4.40 |
| Cash from operations | $1.91bn | $4.33bn | $84.0m | $1.14bn | $2.05bn | $1.02bn | $706.0m | $2.68bn |
| Capital spending | −$287.0m | −$235.0m | −$293.0m | −$360.0m | −$267.0m | −$196.0m | −$322.0m | −$332.0m |
| Free cash flow | $1.63bn | $4.10bn | −$209.0m | $775.0m | $1.79bn | $821.0m | $384.0m | $2.35bn |
| Total assets | $126.44bn | $125.83bn | $121.49bn | $122.75bn | $121.94bn | $119.72bn | $116.89bn | $116.53bn |
| Cash and short-term investments | $37.51bn | $35.56bn | $9.49bn | $8.71bn | $8.56bn | $7.50bn | $8.29bn | $7.87bn |
| Debt | $31.04bn | $31.49bn | $32.18bn | $32.10bn | $30.19bn | $30.00bn | $31.39bn | $27.15bn |
| Shareholders' equity | $44.88bn | $43.90bn | $43.88bn | $43.95bn | $43.72bn | $42.50bn | $41.31bn | $43.77bn |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 8.3% | 10.3% | 9.7% |
| Operating income | -1.4% | 1.0% | 4.2% |
| Net income | -1.3% | 4.4% | 8.3% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 26.6% | 26.6% | 26.6% | 25.0% |
| Operating margin | 4.5% | 4.9% | 5.3% | 5.6% |
| Net margin | 3.1% | 3.3% | 3.5% | 3.6% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 13.7 | 14.3 | 18.6 | 21.0 | 18.6 | 17.6 | 16.2 | 18.4 | 15.4 | 15.6 |
| Price to sales | 0.4 | 0.5 | 0.7 | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | 0.7 | 0.5 |
Market value over time
31 Oct 2016 to 11 Sept 2026, in USD
$32.66bn$91.24bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | -6% | -21% | -7% | 14% | 43% | 1% | 20% | 11% | 54% | 6% |
Dividends and splits
Per share, in the currency the company pays
Paid for 15 years. Last went ex-dividend on 10 Sept 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 5.16 | 6.84 | 6.52 | 5.92 | 5.12 | 4.52 | 3.80 | 3.20 |
- 2-for-1 split · 1 Jun 2005
- 2-for-1 split · 18 Mar 2002
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.